Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Hayden

Showing results (271-280 of 292) with videos related to

Pageof 30
Sort By:
Atherosclerosis|December 4, 2003
Heterozygosity for ABCA1 gene mutations: effects on enzymes, apolipoproteins and lipoprotein particle sizeJ A Kuivenhoven, G K Hovingh, A van Tol, et al.
Human Molecular Genetics|February 1, 1997
Contribution of DNA sequence and CAG size to mutation frequencies of intermediate alleles for Huntington disease: evidence from single sperm analysesS S Chong, E Almqvist, H Telenius, et al.
Circulation|March 10, 2001
Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery diseaseS M Clee, A H Zwinderman, J C Engert, et al.
Pediatric Blood & Cancer|February 27, 2013
Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in childrenH Visscher, C J D Ross, S R Rassekh, et al.
The Journal of Biological Chemistry|June 26, 2001
Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1R R Singaraja, V Bocher, E R James, et al.
The Journal of Clinical Investigation|November 22, 2000
Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotesS M Clee, J J Kastelein, M van Dam, et al.
Neuron|July 13, 1999
A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegenerationJ G Hodgson, N Agopyan, C A Gutekunst, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Ethnic variation and in vivo effects of the -93t-->g promoter variant in the lipoprotein lipase geneE Ehrenborg, S M Clee, S N Pimstone, et al.
Cell Death and Differentiation|January 10, 2004
Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's diseaseE Hermel, J Gafni, S S Propp, et al.
Lancet (London, England)|October 26, 1999
Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol effluxM Marcil, A Brooks-Wilson, S M Clee, et al.
Pageof 30

Showing results (271-280 of 292) with videos related to

Sort By:
Pageof 30
Atherosclerosis|December 4, 2003
Heterozygosity for ABCA1 gene mutations: effects on enzymes, apolipoproteins and lipoprotein particle sizeJ A Kuivenhoven, G K Hovingh, A van Tol, et al.
Human Molecular Genetics|February 1, 1997
Contribution of DNA sequence and CAG size to mutation frequencies of intermediate alleles for Huntington disease: evidence from single sperm analysesS S Chong, E Almqvist, H Telenius, et al.
Circulation|March 10, 2001
Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery diseaseS M Clee, A H Zwinderman, J C Engert, et al.
Pediatric Blood & Cancer|February 27, 2013
Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in childrenH Visscher, C J D Ross, S R Rassekh, et al.
The Journal of Biological Chemistry|June 26, 2001
Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1R R Singaraja, V Bocher, E R James, et al.
The Journal of Clinical Investigation|November 22, 2000
Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotesS M Clee, J J Kastelein, M van Dam, et al.
Neuron|July 13, 1999
A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegenerationJ G Hodgson, N Agopyan, C A Gutekunst, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Ethnic variation and in vivo effects of the -93t-->g promoter variant in the lipoprotein lipase geneE Ehrenborg, S M Clee, S N Pimstone, et al.
Cell Death and Differentiation|January 10, 2004
Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's diseaseE Hermel, J Gafni, S S Propp, et al.
Lancet (London, England)|October 26, 1999
Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol effluxM Marcil, A Brooks-Wilson, S M Clee, et al.
Pageof 30